The company’s groundbreaking device, known as “Blindsight,” promises to revolutionize treatment for the blind. With the backing of the U.S. Food and Drug Administration (FDA), this ...
The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...